Specifically, across different cancer stages, TIMP3 expression was notably lower in colorectal cancer compared to normal tissues, demonstrating statistical significance (p ≤ 0.001), as depicted in Figure 2B. Additionally, male and female tissues did not exhibit any difference in TIMP3 expression levels in COAD patients (Figure 2C). Here, TIMP3 is linked to colon adenocarcinoma.